Neurovirtual and Zynex have signed a major distribution agreement that will make Zynex the exclusive distributor for Neurovirtual’s Neurology and Sleep Diagnostic product line in the United States.

The agreement will allow the company to focus more on new product development and improve its sales and marketing efforts, according to Neurovirtual, which develops and manufactures high-technology medical devices used in sleep medicine and neurology.

“This is a very significant step for Neurovirtual,” said Ed Faria, the company’s CEO. “This agreement will allow Neurovirtual to access resources capable of making our products a top leader in the US.”

The company will continue to provide direct technical and customer support to new and existing customers, with virtually no changes to product warranty or support policy, the company said.

“Neurovirtual products are superior in the industry and represent a key element for Zynex to continue penetrating the neurodiagnostics market,” said Thomas Sandgaard, president and CEO of Zynex. “We believe the agreement with Neurovirtual will provide us with a significant revenue opportunity in our Zynex NeuroDiagnostics subsidiary.”